Skip to main content
Equibles

BOOTHBAY FUND MANAGEMENT, LLC

Position in VERU — Veru Inc.

CIK 1549230 NEW YORK, NY
Back to VERU Full portfolio

Position in VERU

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$69,665
+$2,206 QoQ
Shares Held
31,523
0.0% QoQ
Ownership
0.185%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
12 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in VERU Over Time

Shares Held

Position Value (USD)

Derivatives in VERU

reported options exposure · as of Sep 30, 2022
CallValue
$1,519,488
CallShares
13,190
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BOOTHBAY FUND MANAGEMENT, LLC holds $666,641,771 across 159 Biotechnology names.

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 465,787 $87,232,589
2 ABVX
Abivax S.A.
 563,367 $75,074,286
3 EXEL
Exelixis, Inc.
 804,095 $43,750,808
4 PCVX
Vaxcyte, Inc.
 534,163 $31,050,895
5 COGT
Cogent Biosciences, Inc.
 692,825 $26,812,327
6 CGEM
Cullinan Therapeutics, Inc.
 1,082,611 $19,714,346
7 TNGX
Tango Therapeutics, Inc.
 500,497 $15,645,536
8 AVTX
Avalo Therapeutics, Inc.
 702,051 $12,973,902

All Filings in VERU

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $69,665 31,523
2025-12-31 $67,459 31,523
2025-09-30 $154,010 40,529
2025-06-30 $235,069 405,292
2025-03-31 $198,593 405,292
2024-12-31 $170,900 262,924
2024-09-30 $203,331 264,067
2024-06-30 $221,816 264,067
2024-03-31 $184,846 264,067
2022-09-30 $1,519,488 131,900
2020-06-30 $34,017 10,185
2020-03-31 $40,875 12,500